In the first half of the years 2020-2026, 4582 patients have received treatment or are in the treatment phase for viral hepatitis.
28-07-2026 12:10 Armenia
Viral hepatitis prevention and control is one of the important directions of the healthcare system. Since 2020, the Ministry of Health has been implementing the "Program for the Prevention and Control of Viral Hepatitis," within which the opportunities for early detection, treatment, and prevention of the disease are continuously expanding.
"Within the framework of the program, in the first half of 2020-2026, 4582 patients have received treatment or are in the treatment phase. Patients are provided with modern antiviral medications free of charge and with a complete treatment course, including those in correctional institutions and individuals with co-infections.
Since 2022, a new approach to treatment with the new generation drug "Sofosbuvir/Velpatasvir" has been introduced. It is used for all genotypes of hepatitis C, has high efficacy, and allows for a reduction in the financial burden on patients.
As a result of the program's effectiveness, around 96% recovery is recorded in cases detected early. Of the patients who received treatment from 2020 to 2026, about 4399 have fully recovered.
Viral hepatitis prevention and control measures continue in Armenia. Thanks to vaccinations against hepatitis B, there has been a significant decrease in morbidity, especially among children. In recent years, no acute cases of hepatitis B have been recorded among individuals under 18.
World Hepatitis Day, celebrated on July 28, once again emphasizes the importance of preventing viral hepatitis, early diagnosis, and access to treatment.
Consistent actions are being taken at the state level to prevent viral hepatitis as a public health issue, ensure early detection of diseases, and make effective treatment accessible to citizens.":
Ministry of Health of the Republic of Armenia
* This text was automatically translated by Artificial Intelligence (AI).
ENGLISH
